ロード中...
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/ https://ncbi.nlm.nih.gov/pubmed/28348153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|